FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2325356223> ?p ?o ?g. }

• W2325356223 endingPage "27688" @default.
• W2325356223 startingPage "27676" @default.
• W2325356223 abstract "Human granulocytic myeloid-derived suppressor cells (G-MDSCs) have been described as low-density immunosuppressive CD66b+CD33dimHLA-DR-granulocytes that co-purify with mononuclear cells after density gradient centrifugation of blood from cancer patients. The role of G-MDSCs in Hodgkin (HL) and non-Hodgkin lymphoma (NHL) remains unclear.The percentage and immunophenotype of CD66b+CD33dimHLA-DR-cells were analyzed in PBMCs from HL and B-cell NHL patients (n = 124) and healthy donors (n = 48). The immunosuppressive functions of these cells were tested in vitro. Correlations between CD66b+CD33dimHLA-DR-cells and patient clinicopathological features and outcome, were evaluated.CD66b+CD33dimHLA-DR-cells were increased in PBMCs from HL and B-cell NHL patients as compared to healthy donors: 2.18 (0.02-70.92) vs 0.42 (0.04-2.97), p < 0.0001. Their percentage remained significantly higher even considering HL (n = 31), indolent (n = 31) and aggressive (n = 62) B-cell NHL patients separately: 1.54 (0.28-26.34), 2.15 (0.02-20.08), and 2.96 (0.25-70.92), respectively, p < 0.0001. CD66b+CD33dimHLA-DR-cells in patient PBMCs were mostly composed of mature CD11b+CD16+ low-density neutrophils in an activated status, as revealed by their higher CD11b and CD66b expression as compared to conventionally isolated (normal-density) autologous or healthy donor neutrophils. The in vitro depletion of CD66b+ cells from patient PBMCs restored the proliferation of autologous T cells. Higher frequencies of CD66b+CD33dimHLA-DR- G-MDSCs correlated significantly with unfavorable prognostic index scores and a shorter freedom from disease progression.PBMCs from HL and B-cell NHL patients contain a population of CD66b+CD33dimHLA-DR- G-MDSCs, mostly composed of activated low-density neutrophils with immunosuppressive properties. These findings disclose a previously unknown G-MDSC-mediated mechanism of immune-escape in lymphomas, therefore anticipating possible targets for therapeutic interventions." @default.
• W2325356223 created "2016-06-24" @default.
• W2325356223 creator A5003274863 @default.
• W2325356223 creator A5008332699 @default.
• W2325356223 creator A5037463942 @default.
• W2325356223 creator A5051185090 @default.
• W2325356223 creator A5054072348 @default.
• W2325356223 creator A5055628496 @default.
• W2325356223 creator A5056541118 @default.
• W2325356223 creator A5066461145 @default.
• W2325356223 creator A5067105482 @default.
• W2325356223 creator A5068408771 @default.
• W2325356223 creator A5076061836 @default.
• W2325356223 creator A5081086326 @default.
• W2325356223 creator A5085796975 @default.
• W2325356223 date "2016-03-30" @default.
• W2325356223 modified "2023-10-13" @default.
• W2325356223 title "Identification of granulocytic myeloid-derived suppressor cells (G-MDSCs) in the peripheral blood of Hodgkin and non-Hodgkin lymphoma patients" @default.
• W2325356223 cites W1500412381 @default.
• W2325356223 cites W1517888833 @default.
• W2325356223 cites W1570472500 @default.
• W2325356223 cites W1577847722 @default.
• W2325356223 cites W1612749618 @default.
• W2325356223 cites W1911120442 @default.
• W2325356223 cites W1971815003 @default.
• W2325356223 cites W1976965953 @default.
• W2325356223 cites W1989111278 @default.
• W2325356223 cites W2000756990 @default.
• W2325356223 cites W2008717037 @default.
• W2325356223 cites W2010391415 @default.
• W2325356223 cites W2013575415 @default.
• W2325356223 cites W2036965973 @default.
• W2325356223 cites W2054246680 @default.
• W2325356223 cites W2060672294 @default.
• W2325356223 cites W2072706091 @default.
• W2325356223 cites W2081498322 @default.
• W2325356223 cites W2088431383 @default.
• W2325356223 cites W2095940261 @default.
• W2325356223 cites W2097581657 @default.
• W2325356223 cites W2104032278 @default.
• W2325356223 cites W2105565011 @default.
• W2325356223 cites W2118275084 @default.
• W2325356223 cites W2122403898 @default.
• W2325356223 cites W2126431419 @default.
• W2325356223 cites W2132132140 @default.
• W2325356223 cites W2133201432 @default.
• W2325356223 cites W2134401635 @default.
• W2325356223 cites W2138654133 @default.
• W2325356223 cites W2141681661 @default.
• W2325356223 cites W2143145234 @default.
• W2325356223 cites W2143473356 @default.
• W2325356223 cites W2144083071 @default.
• W2325356223 cites W2152677909 @default.
• W2325356223 cites W2158466638 @default.
• W2325356223 cites W2168205651 @default.
• W2325356223 cites W2328676772 @default.
• W2325356223 cites W4205736005 @default.
• W2325356223 cites W4293203547 @default.
• W2325356223 doi "https://doi.org/10.18632/oncotarget.8507" @default.
• W2325356223 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5053680" @default.
• W2325356223 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/27050283" @default.
• W2325356223 hasPublicationYear "2016" @default.
• W2325356223 type Work @default.
• W2325356223 sameAs 2325356223 @default.
• W2325356223 citedByCount "66" @default.
• W2325356223 countsByYear W23253562232016 @default.
• W2325356223 countsByYear W23253562232017 @default.
• W2325356223 countsByYear W23253562232018 @default.
• W2325356223 countsByYear W23253562232019 @default.
• W2325356223 countsByYear W23253562232020 @default.
• W2325356223 countsByYear W23253562232021 @default.
• W2325356223 countsByYear W23253562232022 @default.
• W2325356223 countsByYear W23253562232023 @default.
• W2325356223 crossrefType "journal-article" @default.
• W2325356223 hasAuthorship W2325356223A5003274863 @default.
• W2325356223 hasAuthorship W2325356223A5008332699 @default.
• W2325356223 hasAuthorship W2325356223A5037463942 @default.
• W2325356223 hasAuthorship W2325356223A5051185090 @default.
• W2325356223 hasAuthorship W2325356223A5054072348 @default.
• W2325356223 hasAuthorship W2325356223A5055628496 @default.
• W2325356223 hasAuthorship W2325356223A5056541118 @default.
• W2325356223 hasAuthorship W2325356223A5066461145 @default.
• W2325356223 hasAuthorship W2325356223A5067105482 @default.
• W2325356223 hasAuthorship W2325356223A5068408771 @default.
• W2325356223 hasAuthorship W2325356223A5076061836 @default.
• W2325356223 hasAuthorship W2325356223A5081086326 @default.
• W2325356223 hasAuthorship W2325356223A5085796975 @default.
• W2325356223 hasBestOaLocation W23253562231 @default.
• W2325356223 hasConcept C114684123 @default.
• W2325356223 hasConcept C121608353 @default.
• W2325356223 hasConcept C126322002 @default.
• W2325356223 hasConcept C137061746 @default.
• W2325356223 hasConcept C167672396 @default.
• W2325356223 hasConcept C179185449 @default.
• W2325356223 hasConcept C196166836 @default.
• W2325356223 hasConcept C202751555 @default.
• W2325356223 hasConcept C203014093 @default.
• W2325356223 hasConcept C2779282312 @default.

• next